FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Masato Homma

Research Profile

Chemicals & Drugs

Procedures

Physiology

Concepts & Ideas

Co-author Network

Publications

TOP 3
K Momo; Tadanori Sasaki; Masato Homma; Sayaka Matsumoto; Yukinao Kohda
[Clinical survey of tizanidine-induced adverse effects--impact of concomitant drugs providing cytochrome P450 1A2 modification--].
Yoshiharu Suzuki; Masato Abei; Masato Homma; Ichinosuke Hyodo; Yukinao Kohda
Impact of solute carrier family 29 member 1 (SLC29A1) single nucleotide polymorphisms on mRNA expression in peripheral blood mononuclear cells.
Kosuke Doki; Masato Homma; Kazutaka Aonuma; Keisuke Kuga; Yukinao Kohda
CYP2D6 genotype affects age-related decline in flecainide clearance: a population pharmacokinetic analysis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Masato Homma (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: K Momo; Tadanori Sasaki; Masato Homma; Sayaka Matsumoto; Yukinao Kohda
[Clinical survey of tizanidine-induced adverse effects--impact of concomitant drugs providing cytochrome P450 1A2 modification--].
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 2013;133(2):275-81.
2013: Yoshiharu Suzuki; Masato Abei; Masato Homma; Ichinosuke Hyodo; Yukinao Kohda
Impact of solute carrier family 29 member 1 (SLC29A1) single nucleotide polymorphisms on mRNA expression in peripheral blood mononuclear cells.
Biological & pharmaceutical bulletin 2013;36(1):144-6.
2012: Kosuke Doki; Masato Homma; Kazutaka Aonuma; Keisuke Kuga; Yukinao Kohda
CYP2D6 genotype affects age-related decline in flecainide clearance: a population pharmacokinetic analysis.
Pharmacogenetics and genomics 2012;22(11):777-83.
2011: Masaaki Watanabe; Kenji Momo; Yasushi Okoshi; Tetsuro Wada; Shigeru Chiba; Akira Hara; Masato Homma; Yukinao Kohda
Effects of voriconazole co-administration on oxycodone-induced adverse events: a case in the retrospective survey.
European journal of clinical pharmacology 2011;67(8):859-61.
2011: Toshimi Kobayashi; Masato Homma; K Momo; Daisuke Kobayashi; Yukinao Kohda
A simple chromatographic method for determining norfloxacin and enoxacin in pharmacokinetic study assessing CYP1A2 inhibition.
Biomedical chromatography : BMC 2011;25(4):435-8.
2010: Kosuke Doki; Masato Homma; Tetsuo Hori; Takashi Tomita; Yuichi Hasegawa; Satoshi Ito; Kiyoshi Fukunaga; Michio Kaneko; Shigeru Chiba; Takayuki Sumida; Nobuhiro Ohkohchi; Yukinao Kohda
Difference in blood tacrolimus concentration between ACMIA and MEIA in samples with low haematocrit values.
The Journal of pharmacy and pharmacology 2010;62(9):1185-8.
2010: K Momo; Masato Homma; Yoshiko Osaka; Shin-ichi Inomata; Makoto Tanaka; Yukinao Kohda
Effects of mexiletine, a CYP1A2 inhibitor, on tizanidine pharmacokinetics and pharmacodynamics.
Journal of clinical pharmacology 2010;50(3):331-7.
2009: Masato Homma; Hiroyuki Hosono; Yuichi Hasegawa; Yukinao Kohda
Morphological transformation and phosphatidylserine exposure in erythrocytes treated with ribavirin.
Biological & pharmaceutical bulletin 2009;32(11):1940-2.
2009: Kosuke Doki; Masato Homma; Keisuke Kuga; Kazutaka Aonuma; Yukinao Kohda
Effects of CYP2D6 genotypes on age-related change of flecainide metabolism: involvement of CYP1A2-mediated metabolism.
British journal of clinical pharmacology 2009;68(1):89-96.
2009: Aya Nakajima; Kosuke Doki; Masato Homma; Terumi Sagae; Reiko Saito; Satoshi Ito; Takayuki Sumida; Yukinao Kohda
[Investigation of glucocorticoid-induced side effects in patients with autoimmune diseases].
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 2009;129(4):445-50.
2009: Kunihiro Suzuki; Kosuke Doki; Masato Homma; Hirofumi Tamaki; Satoko Hori; Hisakazu Ohtani; Yasufumi Sawada; Yukinao Kohda
Co-administration of proton pump inhibitors delays elimination of plasma methotrexate in high-dose methotrexate therapy.
British journal of clinical pharmacology 2009;67(1):44-9.
2008: Takashi Tomita; Masato Homma; Yuichi Hasegawa; Hiroshi Kojima; Nobuhiro Ohkohchi; Tetsuo Hori; Michio Kaneko; Yasuko Nakano; Takashi Tobe; Yukinao Kohda
Use of sample hematocrit value to correct blood tacrolimus concentration derived by microparticle enzyme immunoassay.
Biological & pharmaceutical bulletin 2008;31(6):1250-3.
2008: T Yamashiro; Masato Homma; Yukinao Kohda
Assessment of hypnotic effects and patient satisfaction in empirical use of sleep medicines.
Journal of clinical pharmacy and therapeutics 2008;33(3):273-8.
2008: Masato Homma; Y Inoue; Y Hasegawa; H Kojima; Yukinao Kohda
Blood ribavirin concentration in high-dose ribavirin for adenovirus-induced haemorrhagic cystitis - a case report.
Journal of clinical pharmacy and therapeutics 2008;33(1):75-8.
2007: Kosuke Doki; Masato Homma; Keisuke Kuga; Kazutaka Aonuma; Satoshi Sakai; Iwao Yamaguchi; Yukinao Kohda
Gender-associated differences in pharmacokinetics and anti-arrhythmic effects of flecainide in Japanese patients with supraventricular tachyarrhythmia.
European journal of clinical pharmacology 2007;63(10):951-7.
2007: Kosuke Doki; Masato Homma; Keisuke Kuga; S Kawano; K Aonuma; Iwao Yamaguchi; Yukinao Kohda
Impact of serum flecainide level on control of atrial fibrillation in a case treated with cardiac resynchronization therapy.
Journal of clinical pharmacy and therapeutics 2007;32(4):409-11.
2006: Wen Qian; Masato Homma; Fumio Itagaki; Hirokazu Tachikawa; Yoichi Kawanishi; Katsuyoshi Mizukami; Takashi Asada; Shinichi Inomata; Katsuya Honda; Nobuhiro Ohkohchi; Yukinao Kohda
MDR1 gene polymorphism in Japanese patients with schizophrenia and mood disorders including depression.
Biological & pharmaceutical bulletin 2006;29(12):2446-50.
2006: Kosuke Doki; Masato Homma; Keisuke Kuga; Kazutomi Kusano; Shigeyuki Watanabe; Iwao Yamaguchi; Yukinao Kohda
Effect of CYP2D6 genotype on flecainide pharmacokinetics in Japanese patients with supraventricular tachyarrhythmia.
European journal of clinical pharmacology 2006;62(11):919-26.
2006: Masato Homma; Miya Ishihara; Wen Qian; Yukinao Kohda
[Effects of long term administration of Shakuyaku-kanzo-To and Shosaiko-To on serum potassium levels].
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 2006;126(10):973-8.
2006: Masato Homma; Kenji Sumiya; Yasuyuki Kambayashi; Shinichi Inomata; Yukinao Kohda
Assessment of clonidine orally disintegrating tablet for pre-anesthetic medication in pediatric surgery.
Biological & pharmaceutical bulletin 2006;29(2):321-3.
2006: Yoichi Inoue; Masato Homma; Yasushi Matsuzaki; Minoru Shibata; Takuya Matsumura; Takayoshi Ito; Yukinao Kohda
Erythrocyte ribavirin concentration for assessing hemoglobin reduction in interferon and ribavirin combination therapy.
Hepatology research : the official journal of the Japan Society of Hepatology 2006;34(1):23-7.
2005: Shinichi Inomata; Atsushi Nagashima; Fumio Itagaki; Masato Homma; Masuhiro Nishimura; Yoshiko Osaka; Kazuhiko Okuyama; Einosuke Tanaka; Takako Nakamura; Yukinao Kohda; Shinsaku Naito; Masayuki Miyabe; Hidenori Toyooka
CYP2C19 genotype affects diazepam pharmacokinetics and emergence from general anesthesia.
Clinical pharmacology and therapeutics 2005;78(6):647-55.
2005: Takeshi Kawata; Masato Homma; Yoshihiro Kakiuchi; Shinichi Inomata; Masayuki Miyabe; Daisuke Kobayashi; Yasunori Morimoto; Yukinao Kohda
Liquid chromatographic determination of plasma ropivacaine for assessing pharmacokinetics of the viscous preparation.
Biological & pharmaceutical bulletin 2005;28(12):2271-3.
2005: Takashi Tomita; Masato Homma; Kenji Yuzawa; Nobuhiro Ohkohchi; Tetsuo Hori; Michio Kaneko; Yuichi Hasegawa; Hiroshi Kojima; Toshiro Nagasawa; Yukinao Kohda
Effects of hematocrit value on microparticle enzyme immunoassay of tacrolimus concentration in therapeutic drug monitoring.
Therapeutic drug monitoring 2005;27(1):94-7.
2005: Masato Homma; Keisuke Kuga; Kosuke Doki; Kumi Katori; Iwao Yamaguchi; Kenji Sugibayashi; Yukinao Kohda
Assessment of serum flecainide trough levels in patients with tachyarrhythmia.
The Journal of pharmacy and pharmacology 2005;57(1):47-51.
2004: Kenji Momo; Kosuke Doki; Hiroyuki Hosono; Masato Homma; Yukinao Kohda
Drug interaction of tizanidine and fluvoxamine.
Clinical pharmacology and therapeutics 2004;76(5):509-10.
2004: Fumio Itagaki; Masato Homma; Kohji Takara; Noriaki Ohnishi; Teruyoshi Yokoyama; Toshiyuki Sakaeda; Tatsurou Yagami; Hironao Kobayashi; Noboru Okamura; Yukinao Kohda
Effect of rabeprazole on MDR1-mediated transport of Rhodamine 123 in Caco-2 and Hvr100-6 cells.
Biological & pharmaceutical bulletin 2004;27(10):1694-6.
2004: Yoichi Inoue; Masato Homma; Yasushi Matsuzaki; Minoru Shibata; Takuya Matsumura; Takayoshi Ito; Keiji Mitamura; Naomi Tanaka; Yukinao Kohda
Liquid chromatography assay for routine monitoring of cellular ribavirin levels in blood.
Antimicrobial agents and chemotherapy 2004;48(10):3813-6.
2004: Kosuke Doki; Masato Homma; Keisuke Kuga; Shigeyuki Watanabe; Iwao Yamaguchi; Yukinao Kohda
Simultaneous determination of serum flecainide and its metabolites by using high performance liquid chromatography.
Journal of pharmaceutical and biomedical analysis 2004;35(5):1307-12.
2004: Fumio Itagaki; Masato Homma; Kenji Yuzawa; Masuhiro Nishimura; Shinsaku Naito; Nobuhiko Ueda; Nobuhiro Ohkohchi; Yukinao Kohda
Effect of lansoprazole and rabeprazole on tacrolimus pharmacokinetics in healthy volunteers with CYP2C19 mutations.
The Journal of pharmacy and pharmacology 2004;56(8):1055-9.
2003: Kumi Katori; Masato Homma; Keisuke Kuga; Iwao Yamaguchi; Kenji Sugibayashi; Yukinao Kohda
Liquid chromatographic determination of unbound flecainide in therapeutic drug monitoring.
Journal of pharmaceutical and biomedical analysis 2003;32(2):375-80.
2003: Kenji Sumiya; Masato Homma; Machiko Watanabe; Yasuyuki Baba; Shinichi Inomata; Shin-ichi Kihara; Hidenori Toyooka; Yukinao Kohda
Sedation and plasma concentration of clonidine hydrochloride for pre-anesthetic medication in pediatric surgery.
Biological & pharmaceutical bulletin 2003;26(4):421-3.
2002: Yoshihiro Kakiuchi; Taeko Fukuda; Masayuki Miyabe; Masato Homma; Hidenori Toyooka; Yukinao Kohda
Chromatographic determination of free lidocaine and its active metabolites in plasma from patients under epidural anesthesia.
International journal of clinical pharmacology and therapeutics 2002;40(11):493-8.
2002: Fumio Itagaki; Masato Homma; Kenji Yuzawa; K Fukao; Yukinao Kohda
Drug interaction of tacrolimus and proton pump inhibitors in renal transplant recipients with CYP2C19 gene mutation.
Transplantation proceedings 2002;34(7):2777-8.
2002: Miya Ishihara; Masato Homma; Eiko Kuno; Machiko Watanabe; Yukinao Kohda
[Combination use of kampo-medicines and drugs affecting intestinal bacterial flora].
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 2002;122(9):695-701.
2002: Rei Nakagawa; Masato Homma; Keisuke Kuga; Iwao Yamaguchi; Daisuke Kobayashi; Yasunori Morimoto; Yukinao Kohda
High performance liquid chromatography for routine monitoring of serum flecainide.
Journal of pharmaceutical and biomedical analysis 2002;30(1):171-4.
2002: Masato Homma; Fumio Itagaki; Kenji Yuzawa; Katashi Fukao; Yukinao Kohda
Effects of lansoprazole and rabeprazole on tacrolimus blood concentration: case of a renal transplant recipient with CYP2C19 gene mutation.
Transplantation 2002;73(2):303-4.
2001: Fumio Itagaki; T Hori; T Tomita; Yoshihiro Kakiuchi; Y Yamamoto; Masato Homma; M Kaneko; Yukinao Kohda
Effect of ascites on tacrolimus disposition in a liver transplant recipient.
Therapeutic drug monitoring 2001;23(6):644-6.
2000: Masato Homma; M Takeda; Y Yamamoto; H Suga; M Horiuchi; S Satoh; Yukinao Kohda
[Consultation and survey for drug interaction in outpatients taking the medicines potentially interact with St. John's Wort].
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 2000;120(12):1435-40.